Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
Tim Harrison, Ian D. Pavord, James D. Chalmers, Glenn Whelan, Malin Fagerås, Annika Rutgersson, Laura Belton, Shahid Siddiqui, Per Gustafson

ERJ Open Research Apr 2020, 6 (2) 00333-2019; DOI: 10.1183/23120541.00333-2019
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Patricia van Velzen, Gerben ter Riet, Paul Brinkman, Peter J. Sterk, Jan M. Prins

ERJ Open Research Apr 2020, 6 (2) 00099-2020; DOI: 10.1183/23120541.00099-2020
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
Nicola A. Hanania, Alberto Papi, Antonio Anzueto, Fernando J. Martinez, Kimberly A. Rossman, Christy S. Cappelletti, Elizabeth A. Duncan, Jack S. Nyberg, Paul M. Dorinsky

ERJ Open Research Apr 2020, 6 (2) 00187-2019; DOI: 10.1183/23120541.00187-2019
Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis
Katherine B. Hisert, Timothy P. Birkland, Kelly Q. Schoenfelt, Matthew E. Long, Brenda Grogan, Suzanne Carter, W. Conrad Liles, Edward F. McKone, Lev Becker, Anne M. Manicone

ERJ Open Research Apr 2020, 6 (2) 00318-2019; DOI: 10.1183/23120541.00318-2019
Enoximone in status asthmaticus
Oscar Schulz, Olaf Wiesner, Tobias Welte, Benjamin-Alexander Bollmann, Hendrik Suhling, Marius M. Hoeper, Markus Busch

ERJ Open Research Jan 2020, 6 (1) 00367-2019; DOI: 10.1183/23120541.00367-2019
Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies
Rupert Jones, Andy Nicholls, Dominy Browning, Nawar Diar Bakerly, Ashley Woodcock, Jørgen Vestbo, David A. Leather, Loretta Jacques, James Lay-Flurrie, Henrik Svedsater, Susan Collier

ERJ Open Research Jan 2020, 6 (1) 00193-2019; DOI: 10.1183/23120541.00193-2019
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
Mario Castro, Klaus F. Rabe, Jonathan Corren, Ian D. Pavord, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Megan S. Rice, Jaman Maroni, Paul Rowe, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Ariel Teper

ERJ Open Research Jan 2020, 6 (1) 00204-2019; DOI: 10.1183/23120541.00204-2019
Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Katerina Antoniou, Katerina Markopoulou, Argyrios Tzouvelekis, Athina Trachalaki, Eirini Vasarmidi, Jiannis Organtzis, Vasilios Tzilas, Evangelos Bouros, Georgia Kounti, Christina Rampiadou, Serafeim-Chrysovalantis Kotoulas, Fotini Bardaka, Eleni Bibaki, Evangelia Fouka, Georgios Meletis, Stavros Tryfon, Zoe Daniil, Despina Papakosta, Demosthenes Bouros

ERJ Open Research Jan 2020, 6 (1) 00172-2019; DOI: 10.1183/23120541.00172-2019
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Brian D. Kent, Grainne d'Ancona, Mariana Fernandes, Linda Green, Cris Roxas, Louise Thomson, Alexandra M. Nanzer, Joanne Kavanagh, Sangita Agarwal, David J. Jackson

ERJ Open Research Jan 2020, 6 (1) 00311-2019; DOI: 10.1183/23120541.00311-2019
Effect of long-acting β-agonists/glucocorticoids on human airway epithelial cell cytokine, transcriptomic and oxidative stress responses to cannabis smoke
Ryan D. Huff, Jennifer A. Aguiar, Wayne Tse, Martin R. Stämpfli, Brendan J. McConkey, Andrew C. Doxey, Jeremy A. Hirota

ERJ Open Research Jan 2020, 6 (1) 00265-2019; DOI: 10.1183/23120541.00265-2019

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us